Revenue
36.3 thousand Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg
2025 · Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg
Exact inputs and evidence
- Revenue: 36251 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg Source
Fundies. English
GridAI Technologies Corp.
EDGARAnnual consolidated revenue for 2025: about Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 36.25K, using the latest reported figures.
Latest fiscal year
Operating margin
-19,539.98%
2025 · %
Operating cash flow
-5.7 million Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg
2025 · Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg
Exact inputs and evidence
- Operating Cash Flow: -5702824 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg Source
- Cash and cash equivalents
- Not available
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-30.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2025-12-31
- Operating income: 2 of 11 periods available· newest 2025-12-31
- Net income: 2 of 11 periods available· newest 2025-12-31
- Operating cash flow: 2 of 11 periods available· newest 2025-12-31
- Capital expenditure: Multiple units; comparison withheld· newest 2021-12-31
- Total assets: Multiple units; comparison withheld· newest 2025-12-31
- Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
- Current assets: Multiple units; comparison withheld· newest 2025-12-31
- Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
- Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 11.67 millionPrior period
−Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 18.06 million
–
Current period
−Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 6.39 million
–
Exact inputs and evidence
-6392654 − -18059336 = 11666682 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg
-18059336 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-6392654 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 3.51 millionPrior period
−Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 9.22 million
–
Current period
−Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 5.7 million
–
Exact inputs and evidence
-5702824 − -9217823 = 3514999 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg
-9217823 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-5702824 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 36,251 100% of revenue
- Cost of revenue Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 693,683 1,914% of revenue
- Operating expenses Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 6.43 million 17,726% of revenue
- Operating income −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 7.08 million −19,540% of revenue
- Tax, interest and other Derived −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 690,784 −1,906% of revenue
- Net income −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 6.39 million −17,634% of revenue
Cash
- Operating cash flow −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 5.7 million −15,731% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2025 Operating loss: operating costs were 19,640% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2025 2025-01-01 – 2025-12-31 | 36251 | 7119689 Derived | -7083438 | -690784 Derived | -6392654 | Unavailable | Source
|
Amounts are exact, in Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 36.3K 2025
Values and sources
| Period | Series | Value(Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg) | Source evidence |
|---|---|---|---|
| 2025 | Revenue | 36251 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -19,540% 2025
Net margin -17,634.4% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Operating margin | -19,540% |
|
| 2025 | Net margin | -17,634.4% |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg -5.7M 2025
Values and sources
| Period | Series | Value(Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg) | Source evidence |
|---|---|---|---|
| 2025 | Operating cash flow | -5702824 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg) | Source evidence |
|---|---|---|---|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2024 2024-01-01 – 2024-12-31 | −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 18.06 million Exact valueExact value: -18059336 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 2024-01-01 – 2024-12-31: -18059336 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 9.22 million Exact valueExact value: -9217823 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 2024-01-01 – 2024-12-31: -9217823 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 6.39 million Exact valueExact value: -6392654 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 2025-01-01 – 2025-12-31: -6392654 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 5.7 million Exact valueExact value: -5702824 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg 2025-01-01 – 2025-12-31: -5702824 Unit_Standard_USD_t8oLXsGrtEqIaSnlYN_xGg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
82 filings · 3,504 latest values · 3,504 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001604191, 1604191, AZRX, ENTO, FWBI, GRDX, edgar:1604191
Also known as AZURRX BIOPHARMA, INC., AzurRx BioPharma, Inc., AzurRx BioPharma, Inc. , BioPharma d'Azur, Inc., ENTERO THERAPEUTICS, INC., Entero Therapeutics, Inc., FIRST WAVE BIOPHARMA, INC., First Wave BioPharma, Inc., GRIDAI TECHNOLOGIES CORP, GridAI Technologies Corp.